Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types
Completed
Conditions studied: Retinal Vascular, Normal Eyes
In brief
Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations
Key facts
- Study ID
- NCT04604002
- Run by
- Heidelberg Engineering GmbH
- People needed
- 86
- Starts
- 2020-10-15
- Expected to finish
- 2022-01-04
- Last updated by the study team
- 2024-02-28
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All Populations:
- Able and willing to undergo the test procedures, sign informed consent, and follow instructions.
- Age ≥ 22
- Normal Population:
- Subjects without uncontrolled systemic conditions, as determined by the Investigator 4. Subjects without ocular disease, as determined by the Investigator 5. Corrected visual acuity ≥ 20/40 6. No reported history of ocular surgical intervention (except for refractive or cataract surgery)
- Pathology Population:
- Subjects with vascular abnormalities such as retinal ischemia, microaneurysms, choroidal neovascularization, retinal neovascularization in at least one eye
You may not qualify if…
- All Populations:
- Subjects unable to read or write
- Subjects with ocular media not sufficiently clear to obtain acceptable study-related imaging
- Subjects who cannot tolerate the imaging procedures
- Subjects without an accompanying structural OCT and CFP image for an acceptable OCTA image
Where it is running
- Southeast Retina Center — Augusta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.